Physician profile
Janine E Senior
NPI 1154321503
$2,594.15
in general payments reported to CMS, 2019-2025
24 companies · $783 in 2025
The $783 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $142 · 2021: $271 · 2022: $236 · 2023: $303 · 2024: $463 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.17 |
| Education | $136.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $410.17 | 2019-2025 | |
| Astellas Pharma US INC | $407.83 | 2024-2025 | Veozah |
| Abbvie INC. | $354.57 | 2019-2024 | Liletta |
| Biogen, INC. | $189.75 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $188.23 | 2023-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $167.21 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $140.95 | 2023-2025 | |
| Hologic Sales and Service, LLC | $123.45 | 2024-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Coopersurgical, INC. | $111.86 | 2019-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $101.89 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $80.63 | 2019 | |
| Sumitomo Pharma America, INC. | $40.95 | 2024-2025 | Myfembree |
| Myovant Sciences INC. | $38.62 | 2022 | |
| Minerva Surgical, INC | $38.23 | 2025 | |
| Allergan, INC. | $35.28 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $25.37 | 2022-2023 | |
| Mylan Pharmaceuticals INC. | $22.80 | 2021 | |
| Roche Diagnostics Corporation | $22.10 | 2019 | |
| Covidien LP | $20.03 | 2019 | |
| Lupin INC. | $17.23 | 2020 | |
| Meditrina | $17.17 | 2025 | |
| Avion Pharmaceuticals | $13.89 | 2022 | |
| Daiichi Sankyo INC. | $13.03 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janine Senior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.